- Presentation title: “Long-Term Persistence of Anti-HBs Antibodies after Vaccination with a 3-Antigen HBV Vaccine Compared with a Single-Antigen HBV Vaccine” Timo Vesikari, M.D., Ph.D., Professor ...

After getting go-aheads from multiple regulatory agencies, VBI Vaccines started phase 3 testing of its hepatitis B vaccine Sci-B-Vac against its future rival, GSK's Engerix-B, aiming to file for ...

There's no question that the biggest reason to consider buying shares of VBI remains the potential for Sci-B-Vac. The vaccine has already been approved in Israel. VBI announced positive results from a ...